Physicochemical Properties, Morphology and Functional Group Analyses of Gelatin Extracted from Croaker Fish (Pseudotolithus senegalensis) Scale for Suitability in Biomedical Applications

Autor: Ochulor EF, Gbenebor OP, Lawal IO

Challenges are evident during adoption of some biomaterials in tissue engineering (TM), due to their toxicity, immunogenicity, lack of biocompatibility, biodegradability, and bioactivity. Gelatin, a protein-based biopolymer bridges most of those gaps

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a19f286520da860c5f6eac4c816def

The antibacterial activity of Clausena anisata hook, a South African medicinal plant

Autor: Lawal, IO, Grierson, DS, Afolayan, AJ

Publikováno v: African Journal of Traditional, Complementary and Alternative Medicines; Vol 12, No 1 (2015); 23-27

Background: Clausena anisata Hook also known as Iperepesi in Xhosa language is a medicinal plant used traditionally for the treatment of various ailments and some opportunistic infections associated with tuberculosis (TB). Patients in South Africa ba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::8200e9276762cdae528be6a6ca05e0b9
https://www.ajol.info/index.php/ajtcam/article/view/115453

Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.

Autor: Mushtaq A; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, NE, Atlanta, GA, 30322, USA. aliza.mushtaq.21@gmail.com., Lawal IO; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, NE, Atlanta, GA, 30322, USA., Muzahir S; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, NE, Atlanta, GA, 30322, USA., Friend SC; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA., Bhave M; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA., Meisel JL; Department of Radiology and Translational Genomics, University of Southern California, Los Angeles, USA., Torres MA; Department of Radiation Oncology, Emory University, Atlanta, GA, USA., Styblo TM; Department of Surgery, Emory University, Atlanta, GA, USA., Graham CL; Department of Surgery, Emory University, Atlanta, GA, USA., Kalinsky K; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA., Switchenko J; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA., Ulaner GA; Department of Radiology and Translational Genomics, University of Southern California, Los Angeles, USA.; Molecular Imaging and Therapy, Hoag Family Cancer Institute, Irvine, California, USA., Schuster DM; Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, NE, Atlanta, GA, 30322, USA.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Nov; Vol. 51 (13), pp. 4073-4082. Date of Electronic Publication: 2024 Jul 08.

[ ¹⁸ F]F-Poly(ADP-Ribose) Polymerase Inhibitor Radiotracers for Imaging PARP Expression and Their Potential Clinical Applications in Oncology.

Autor: Ndlovu H; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria 0001, South Africa., Lawal IO; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria 0001, South Africa.; Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA., Mdanda S; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria 0001, South Africa., Kgatle MM; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria 0001, South Africa., Mokoala KMG; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria 0001, South Africa., Al-Ibraheem A; Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Al-Jubeiha P.O. Box 1269, Amman 11941, Jordan., Sathekge MM; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Private Bag X169, Pretoria 0001, South Africa.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Jun 11; Vol. 13 (12). Date of Electronic Publication: 2024 Jun 11.

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.

Autor: Sathekge MM; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa; Nuclear Medicine Research Infrastructure, Pretoria, South Africa. Electronic address: mike.sathekge@up.ac.za., Lawal IO; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa; Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA., Bal C; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India., Bruchertseifer F; European Commission, Joint Research Centre, Karlsruhe, Germany., Ballal S; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India., Cardaci G; GenesisCare, Murdoch, WA, Australia., Davis C; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa., Eiber M; Department of Nuclear Medicine, Klinikum Rechts Der Isar, Technical University of Munich and Bavarian Cancer Research Center (BZKF), Munich, Germany., Hekimsoy T; Department of Nuclear Medicine, Klinikum Rechts Der Isar, Technical University of Munich and Bavarian Cancer Research Center (BZKF), Munich, Germany., Knoesen O; Nuclear Technology Products (NTP), Division of the South African Nuclear Energy Cooperation (NECSA), Pelindaba, South Africa., Kratochwil C; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Lenzo NP; GenesisCare, Murdoch, WA, Australia., Mahapane J; Department of Radiography, University of Pretoria, Pretoria, South Africa., Maserumule LC; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa; Nuclear Medicine Research Infrastructure, Pretoria, South Africa., Mdlophane AH; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa; Nuclear Medicine Research Infrastructure, Pretoria, South Africa., Mokoala KMG; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa; Nuclear Medicine Research Infrastructure, Pretoria, South Africa., Ndlovu H; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa; Nuclear Medicine Research Infrastructure, Pretoria, South Africa., Pant V; Royal Liverpool University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Rathke H; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Reed J; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa., Sen IB; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, India., Singh A; GenesisCare, Murdoch, WA, Australia., Sood A; Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Tauber R; Department of Urology, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Thakral P; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurugram, India., Yadav MP; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India., Morgenstern A; Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa; European Commission, Joint Research Centre, Karlsruhe, Germany.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Feb; Vol. 25 (2), pp. 175-183. Date of Electronic Publication: 2024 Jan 11.